"In unserer Klinik betreuen wir schwangere und gebärende Frauen. Als Klinik eines Universitätsspitals sind wir ein innovatives Zentrum für Forschung und Lehre in der Geburtshilfe. Die damit einhergehende medizinische Kompetenz gewährleistet ein grösstmögliches Mass an Sicherheit."

During the past decade, UniversitätsSpital Zürich - Klinik für Gynäkologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UniversitätsSpital Zürich - Klinik für Gynäkologie" #1 sponsor was "University of Zurich" with 4 trials, followed by "David Scheiner" with 2 trials sponsored, "NovoCure Ltd." with 1 trials sponsored, "OnkoZentrum Zürich AG" with 1 trials sponsored and "Swiss Group for Clinical Cancer Research" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UniversitätsSpital Zürich - Klinik für Gynäkologie" #1 collaborator was "University of Zurich" with 2 trials as a collaborator, "ETH Zurich (Switzerland)" with 1 trials as a collaborator and "Stiftung Swiss Tumor Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UniversitätsSpital Zürich - Klinik für Gynäkologie" are "Breast Cancer" (2 trials), "Stress Urinary Incontinence" (2 trials), "Breast Cancer Female" (1 trials), "ERBB2" (1 trials) and "Metastatic Neoplasm" (1 trials). Many other conditions were trialed in "UniversitätsSpital Zürich - Klinik für Gynäkologie" in a lesser frequency.

Most popular intervention types in "UniversitätsSpital Zürich - Klinik für Gynäkologie" are "Drug" (3 trials), "Device" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bryophyllum pinnatum 50 %, tablets into capsules (verum: 2x2capsules/day)" (1 trials), "NovoTTF-100L(O)" (1 trials), "Paclitaxel" (1 trials), "TachoSil® patches" (1 trials) and "app" (1 trials). Other intervention names were less common.

The vast majority of trials in "UniversitätsSpital Zürich - Klinik für Gynäkologie" are 9 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "UniversitätsSpital Zürich - Klinik für Gynäkologie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in UniversitätsSpital Zürich - Klinik für Gynäkologie, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UniversitätsSpital Zürich - Klinik für Gynäkologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".